Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Deutsche Bank Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $18
Cellebrite DI Analyst Ratings
JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating
Craig-Hallum Maintains Buy on Cellebrite DI, Raises Price Target to $20
A Quick Look at Today's Ratings for Cellebrite(CLBT.US), With a Forecast Between $17 to $17
Analysts Offer Insights on Technology Companies: Coherent Corp (COHR), Cellebrite DI (CLBT) and Grab (GRAB)
Cellebrite DI Price Target Raised to $17.00/Share From $14.00 by Needham
Cellebrite DI Analyst Ratings
Cellebrite's Strong Performance and Promising Outlook Justify Buy Rating
Cellebrite DI (CLBT) Receives a Buy From Craig-Hallum
William Blair Maintains Cellebrite(CLBT.US) With Buy Rating
Analysts Have Conflicting Sentiments on These Technology Companies: Shoals Technologies Group (SHLS) and Cellebrite DI (CLBT)
J.P. Morgan Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $15
Cellebrite DI Analyst Ratings
Lake Street Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $13.5
Lake Street Sticks to Their Buy Rating for Cellebrite DI (CLBT)
Cellebrite DI's Strategic Expansion Into Federal Cybersecurity Market Prompts Buy Rating
Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)
Analysts Offer Insights on Technology Companies: Palantir Technologies (PLTR), Cellebrite DI (CLBT) and Array Technologies (ARRY)